Follica, Inc. is developing novel therapies for conditions and disorders of the hair follicle, the epicenter for the development and replenishment of human hair and skin.

Treatments for conditions of the follicle account for a total market exceeding $10 billion annually, despite a lack of truly effective solutions. Follica has assembled a world class team of scientific, clinical, and industry experts that is harnessing the recent advances in epithelial stem cell biology to identify and develop novel therapeutic approaches to these disorders.